Telomir Pharmaceuticals, Inc. Annual Interest Expense in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Telomir Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate for 2023.
  • Telomir Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.34M.
Interest Expense, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.64M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.